Zacks Research Forecasts HealthEquity FY2028 Earnings

HealthEquity, Inc. (NASDAQ:HQY) – Investment analysts at Zacks Research issued their FY2028 EPS estimates for HealthEquity in a research note issued to investors on Tuesday, April 8th. Zacks Research analyst R. Department forecasts that the company will earn $4.65 per share for the year. The consensus estimate for HealthEquity’s current full-year earnings is $2.32 per share.

A number of other equities research analysts have also recently issued reports on HQY. The Goldman Sachs Group decreased their target price on HealthEquity from $107.00 to $94.00 and set a “neutral” rating for the company in a research report on Thursday, March 27th. Wells Fargo & Company upped their price objective on shares of HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a report on Wednesday, February 26th. KeyCorp dropped their target price on shares of HealthEquity from $120.00 to $110.00 and set an “overweight” rating on the stock in a report on Monday, March 24th. Raymond James upgraded shares of HealthEquity from an “outperform” rating to a “strong-buy” rating and decreased their price target for the company from $120.00 to $115.00 in a report on Tuesday, March 25th. Finally, Barrington Research reiterated an “outperform” rating and issued a $112.00 price objective on shares of HealthEquity in a research note on Friday. One equities research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of $112.58.

HealthEquity Price Performance

NASDAQ HQY opened at $82.20 on Thursday. The firm has a market cap of $7.11 billion, a P/E ratio of 75.41, a price-to-earnings-growth ratio of 1.60 and a beta of 0.49. The stock’s 50-day moving average is $97.63 and its two-hundred day moving average is $96.30. HealthEquity has a fifty-two week low of $65.01 and a fifty-two week high of $115.59. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of the company. Wealthfront Advisers LLC acquired a new position in shares of HealthEquity during the fourth quarter valued at $10,304,089,000. Vanguard Group Inc. boosted its stake in shares of HealthEquity by 1.1% in the 4th quarter. Vanguard Group Inc. now owns 8,976,091 shares of the company’s stock valued at $861,256,000 after purchasing an additional 99,624 shares during the last quarter. FMR LLC grew its position in shares of HealthEquity by 2.4% during the 4th quarter. FMR LLC now owns 5,415,800 shares of the company’s stock worth $519,646,000 after buying an additional 125,684 shares during the period. State Street Corp raised its stake in shares of HealthEquity by 0.8% during the third quarter. State Street Corp now owns 3,131,900 shares of the company’s stock worth $256,346,000 after buying an additional 23,613 shares during the last quarter. Finally, Geode Capital Management LLC lifted its holdings in HealthEquity by 0.5% in the fourth quarter. Geode Capital Management LLC now owns 2,089,398 shares of the company’s stock valued at $200,522,000 after buying an additional 10,421 shares during the period. Institutional investors own 99.55% of the company’s stock.

Insider Transactions at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the transaction, the director now directly owns 78,219 shares in the company, valued at $8,704,992.51. This represents a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Michael Henry Fiore sold 8,881 shares of the business’s stock in a transaction on Friday, April 4th. The shares were sold at an average price of $78.26, for a total transaction of $695,027.06. Following the completion of the sale, the executive vice president now owns 56,655 shares in the company, valued at $4,433,820.30. This represents a 13.55 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 20,381 shares of company stock valued at $1,781,432. 2.20% of the stock is owned by corporate insiders.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.